How do we tackle typical common diseases and contribute to state-of-the-art solutions? Ideas in research and innovations in the field of health-related bioeconomy are delivering answers to these demands. The development of healthy food, the production of biotechnology and of drug research are contributing solutions to these challenges. Thus, there are core aspects such as common diseases, healthy food, drug discovery and precision healthcare. Issues such as epigenetics and epidemiology will be considered as well.
Demographic changes and rising life expectancy increase the need for medical progress to face major widespread diseases such as cancer, diabetes, dementia, infections, or cardiovascular and lung diseases. At the same time, the demand for individual care requirements is growing. These challenges demand new, integrated approaches to healthcare and health research aiming to develop new methods of treatment and prevention.
Whithin Bioeconomy, our campaign focus on the following specific areas:
Biotechnology & Drug Discovery
Biotechnology and Drug Discovery have become tremendously useful in clinical research and trials, gene therapy and in diagnostics. Both topics address the development of new therapies and diagnostics using research tools and innovations in bioeconomy which comprise both plants and food research, and industrial biotechnology. The aim is to find vaccines and pharmaceuticals as well as drugs for use in stem cell research. A further aim of drug discovery is to count against antibiotic resistance and the threat of multi-resistant bacteria.
Genetic make-up, lifestyle, gender and age are some of the many individual factors that influence our health and the course of potential diseases. Successful medical research reflects these individual aspects and the needs of every person. Many new processes and standards, molecular biology research on human genetics as an example, are necessary to take advantage of the opportunities offered by individualized health. Thus, the development of tailored therapies and products is the primary aim.
Promising epidemiologic research implicates epigenetics in disease risk and progression, and suggests epigenetic status depends on environmental risks as well as genetic predisposition. Epigenetics may represent a mechanistic link between environmental exposures, or genetics, and many common diseases, or may simply provide a quantitative biomarker for exposure or disease for areas of epidemiology currently lacking such measures.
Leading a healthy life needs prevention and healthy nutrition. Healthy, secure and sustainable food is a major factor that influences our individual health. Bio-based chemicals such as the production of vitamins or alternative sources of protein contribute to the prevention of people suffering from chronic diseases, which are often caused by unhealthy food. Solutions are the development of recipes and functional food additions, as well as enhancing increased use of vegetable ingredients.